Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective.
Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
Boston Children’s spinout Mightier, which makes biofeedback games to help children improve their emotional resilience, has raised $6.6 million in Series A funding, bringing the company’s total funding to $10.1 million.
Foxkiser led the round, with additional contributions from new investors Asset Management Ventures and FundRx, and existing investors including Founder Collective, Slow Ventures...
About the author: Skip Fleshman is a partner at Asset Management Ventures who has invested in companies such as Proteus Digital Health, WellDoc, HealthTap, Evidation Health, Reify Health, Lark and Welkin. You can follow him on Twitter @skipfleshman and @amv.
Digital health technologies will transform healthcare. Mobile phones have given health care providers the ability to engage with patients 24...
Right after reporting that the month of August had an unusual four acquisitions, we had nearly as many in just the first week of September. It seems, going purely on volume, like M&A in digital health is picking up. This week we saw iHealth Labs acquire eDevice for $100 million, HMS Holdings buying Essette for $20 million, and HCA buying Mobile Heartbeat for an undisclosed amount. For a round...
Welkin Health, a San Francisco-based population health management company that provides a combination of mobile, web, and telephone-based coaching programs, has raised $2 million in seed funding and announced its first major pilot, which is with Humana's Innovation Group. Investors in the seed round include Rock Health, Asset Management Ventures, Great Oaks VC, iSeed VC, a direct investment from...
Skip Fleshman, a Managing Partner at Asset Management Ventures, shared a few tips for those mobile health startups looking to become more that just "one-trick pony" developers of successful apps. In order to capitalize on their real potential and become a long-term, viable business, Fleshman has a few lessons learned to share based on his firm's investments in a number of health startups,...
